NA
CVS icon

NewEdge Advisors’s CVS Health CVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.88M Sell
85,269
-13,907
-14% -$959K 0.03% 517
2025
Q1
$6.72M Buy
99,176
+41,871
+73% +$2.84M 0.04% 422
2024
Q4
$2.57M Sell
57,305
-4,749
-8% -$213K 0.02% 725
2024
Q3
$3.9M Sell
62,054
-4,149
-6% -$261K 0.03% 559
2024
Q2
$3.91M Sell
66,203
-1,889
-3% -$112K 0.03% 524
2024
Q1
$5.43M Buy
68,092
+8,256
+14% +$659K 0.05% 367
2023
Q4
$4.62M Sell
59,836
-14,105
-19% -$1.09M 0.04% 375
2023
Q3
$5.16M Sell
73,941
-24,159
-25% -$1.69M 0.06% 317
2023
Q2
$6.78M Sell
98,100
-16,228
-14% -$1.12M 0.08% 252
2023
Q1
$8.41M Sell
114,328
-297,551
-72% -$21.9M 0.11% 203
2022
Q4
$9.7M Buy
411,879
+14,968
+4% +$352K 0.26% 87
2022
Q3
$37.9M Buy
396,911
+24,671
+7% +$2.35M 0.62% 25
2022
Q2
$34.5M Buy
372,240
+14,831
+4% +$1.37M 0.57% 29
2022
Q1
$36.2M Buy
357,409
+295,071
+473% +$29.9M 0.58% 34
2021
Q4
$6.43M Buy
62,338
+28,145
+82% +$2.9M 0.1% 203
2021
Q3
$2.9M Buy
34,193
+1,075
+3% +$91.2K 0.07% 246
2021
Q2
$2.76M Buy
33,118
+2,132
+7% +$178K 0.07% 248
2021
Q1
$2.33M Buy
30,986
+5,997
+24% +$451K 0.07% 254
2020
Q4
$1.71M Sell
24,989
-29,354
-54% -$2.01M 0.06% 287
2020
Q3
$3.17M Buy
54,343
+12,691
+30% +$741K 0.11% 188
2020
Q2
$2.71M Buy
41,652
+3,115
+8% +$202K 0.11% 188
2020
Q1
$2.29M Buy
38,537
+12,482
+48% +$740K 0.11% 177
2019
Q4
$1.94M Buy
26,055
+5,370
+26% +$399K 0.08% 253
2019
Q3
$1.32M Buy
20,685
+6,242
+43% +$399K 0.06% 292
2019
Q2
$787K Sell
14,443
-1,118
-7% -$60.9K 0.05% 308
2019
Q1
$839K Buy
15,561
+6,302
+68% +$340K 0.05% 299
2018
Q4
$607 Sell
9,259
-1,466
-14% -$96 0.04% 330
2018
Q3
$844K Buy
10,725
+632
+6% +$49.7K 0.06% 260
2018
Q2
$658 Buy
10,093
+701
+7% +$46 0.06% 265
2018
Q1
$573K Sell
9,392
-921
-9% -$56.2K 0.07% 251
2017
Q4
$802K Sell
10,313
-1,503
-13% -$117K 0.11% 187
2017
Q3
$878K Buy
11,816
+3,980
+51% +$296K 0.14% 164
2017
Q2
$612K Buy
+7,836
New +$612K 0.11% 175
2016
Q4
Sell
-9,489
Closed -$844K 263
2016
Q3
$844K Buy
9,489
+3,431
+57% +$305K 0.27% 82
2016
Q2
$578K Buy
+6,058
New +$578K 0.24% 82